Tetrahydrocurcumin confers protection against amyloid β-induced toxicity
Authors:
- Mamata MishraMMMamata Mishra
- Pankaj SethPSPankaj Seth
- Shiv Kumar SharmaSSShiv Kumar Sharma
- 5 January 2011
- journal article
- Published by Wolters Kluwer Health in NeuroReport
- Vol. 22 (1) , 23-27
Abstract
Amyloid plaques and neurofibrillary tangles are the hallmarks of Alzheimer's disease. Amyloid β, a primary component of the amyloid plaques, is neurotoxic. Considerable attention has been directed toward identifying compounds with neuroprotective properties. Using rat primary hippocampal cultures, we show that tetrahydrocurcumin (THC), a metabolite of curcumin, shows a protective effect against oligomeric amyloid-β-induced toxicity. We further show that THC reduces amyloid-β-induced (i) increase in the level of reactive oxygen species, (ii) decrease in mitochondrial membrane potential, and (iii) caspase activation. In addition, we show that THC protects human neurons from oligomeric amyloid-β-induced toxicity as well. Thus, THC confers protection against amyloid-β-induced toxicity, and the antioxidant activity may contribute to its protective effect.Keywords
This publication has 24 references indexed in Scilit:
- Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylationFood and Chemical Toxicology, 2008
- Evidence of Aβ‐ and transgene‐dependent defects in ERK‐CREB signaling in Alzheimer’s modelsJournal of Neurochemistry, 2007
- Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug MemantineJournal of Biological Chemistry, 2007
- ERK1/2 Activation Mediates Aβ Oligomer-induced Neurotoxicity via Caspase-3 Activation and Tau Cleavage in Rat Organotypic Hippocampal Slice CulturesJournal of Biological Chemistry, 2006
- RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memoryNature, 2006
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoJournal of Biological Chemistry, 2005
- Aβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targetsNeurochemistry International, 2002
- Alzheimer's Disease Is a Synaptic FailureScience, 2002
- Vaccination with soluble Aβ oligomers generates toxicity‐neutralizing antibodiesJournal of Neurochemistry, 2001
- Amyloid, the presenilins and Alzheimer's diseaseTrends in Neurosciences, 1997